Why Most Innovation Doesn't Create Competitive Advantage

A few years ago, I watched a competitor launch a feature nearly identical to something our team had spent months building. We'd celebrated it as "innovative." We'd invested significant engineering resources. We thought it gave us an edge.

They replicated it in six weeks.

This wasn't theft - they simply looked at what we'd built, recognised it was a good idea, and assigned their engineers to build something similar. No patents were violated. No secrets were stolen. We'd just confused innovation with defensible competitive advantage.

This pattern - companies mistaking novel features for sustainable advantages - is exactly why I founded Radycle. The distinction matters enormously. Innovation creates value. Defensible competitive advantage captures value. Most companies obsess over the former while neglecting the latter, then wonder why their "innovative" products don't translate into sustained market leadership.

Learning to Recognise Real Differentiation

Before I launched entertainment brands or built innovation labs, I was a patent examiner at the European Patent Office. I spent my days assessing whether telecommunications innovations were truly novel and involved inventive steps worthy of patent protection.

I learned two things. First, how to recognise genuine innovation versus incremental improvement. Second, that patents are just one tool for creating defensible advantages; often not the most effective one.

The biggest companies of those days - Nokia, Motorola, Ericsson, Siemens, NEC, Alcatel, among others - filed constantly. But their seminal patents would be opposed, their limitations appealed, and within 18 months of filing, their inventions became public knowledge. Sometimes the smartest strategy was to apply the principles of patentability without actually filing the patent, to build defensibility through execution rather than legal protection.

This insight has shaped how I've thought about competitive advantage ever since - whether launching Discovery's first free-to-air channel in Germany (DMAX), developing children's entertainment properties like Mike the Knight, scaling mobile entertainment franchises to a billion downloads, or building retail innovation labs.

The question isn't "Is this innovative?" It's "Is this defensible?"

The Difference Between Innovation and Defensibility

Innovation is necessary but not sufficient. You can build brilliant technology that creates genuine customer value and still have no competitive advantage. Here's why:

Most "innovative" features fall into one of these categories:

• Novel implementations of common solutions (a better checkout flow, a sleeker interface)

• Technology purchased from vendors (available to anyone with budget)

• Features competitors can quickly replicate (if they can see it, they can build it)

None of these create defensible advantages. They create temporary leads at best.

Defensible competitive advantages are different. They're the gears under the hood - deceptively sophisticated, difficult to replicate, and often non-obvious to outsiders. They manifest as capabilities competitors cannot easily match, even when they can see what you're doing.

A Framework for Defensibility

Over the years, I've developed criteria for evaluating whether technology creates genuine competitive advantage. Not all need to be present, but the more boxes you check, the more defensible your position:

1. Differentiated Problem Solved

Are you solving a problem no one else can solve? Or just solving a common problem in a novel way?

"Operating systems" for various industries are rarely differentiated - they're solving problems already solved by other means. But a capability that addresses a problem competitors haven't figured out how to solve? That's defensible.

At Your.MD (now Healthily), we didn't just build another symptom checker. We built one with Class IIa medical device certification, solving the regulatory and clinical safety problem that kept most digital health companies from being taken seriously by healthcare systems. Competitors could build symptom checkers, but achieving that certification level required clinical governance frameworks they didn't have.

2. Differentiated Solution

Does your solution build a capability no one else has?

At Outfit7, we pioneered using YouTube analytics to validate creative content decisions before major investment. This wasn't just novel - it was a methodology competitors couldn't replicate because it required combining creative instinct with data science in ways traditional entertainment companies weren't structured to do.

The puppet tests I wrote about in my previous post weren't just cheap validation; they were the foundation of a content development process that let us move faster and derisk bigger bets than competitors could.

3. Significant Impact

Does this contribute materially to business success? Or is it an incremental improvement competitors could outpace?

Competitive advantages must manifest as significant drivers of business performance. Small margin improvements don't create moats - they create races to the bottom.

When we built portable battery rental systems like bPOWERd (recently featured in the New York Times), we weren't just adding a convenience feature. We were creating a customer acquisition strategy that worked independently of traditional retail traffic, critical as consumer behaviour evolves. The impact had to be material enough to change the business model.

4. Exclusive Access (Invented Internally)

If you're buying it, so can competitors. If you're outsourcing it, the barrier to entry is probably too low.

This is perhaps the hardest pill to swallow for companies accustomed to "buying innovation" through vendors or acquiring startups. But if it's available externally, it's not defensible. Even exclusive licensing agreements provide weak protection - competitors can usually find alternative solutions or build around your "exclusive" technology.

Real defensibility almost always comes from internal invention. This doesn't mean you can't use external technologies, but your defensible advantage must come from how you combine and apply them in ways only you can.

5. Not Sold Externally

Are you keeping your competitive advantage to yourself? Or selling it to competitors?

This seems obvious but gets violated surprisingly often. Companies build genuinely differentiated technology, then decide to monetise it by selling to the broader market, including competitors.

If you're building technology and selling it to market participants, it's no longer your competitive advantage. Marketplaces or platforms requiring competitor participation will never be defensible competitive advantages.

6. Root Cause, Not Consequence

Is this capability the reason you'll win? Or just a result of past success?

Labelling "our large customer base" as your competitive advantage misses the point. The customer base is a consequence. What's the root cause that built it and will sustain it?

At Outfit7, the competitive advantage wasn't the billion downloads - it was the data-driven content methodology that made those downloads possible and sustainable.

7. Tested in Market

Has this been validated with real customers and real competition?

Differentiation must be constantly tested. Markets evolve, technology advances, and yesterday's moat can become today's parity feature remarkably quickly.

This is why the puppet tests weren't just about cheap validation; they were about building a practice of continuous market testing into our development process. We assumed everything needed proving, not just once but repeatedly.

8. Proprietary Data Sets

Do you have access to data competitors don't?

Data is increasingly the fuel that powers defensible advantages, especially in AI-driven businesses. But not all data is equally defensible.

At Your.MD, our proprietary dataset came from millions of symptom-checking sessions combined with clinical validation from healthcare professionals. Competitors could build symptom checkers, but replicating that specific combination of user behaviour data and clinical expertise would take years.

The key is ensuring your data is comprehensive, accurate, diverse, properly labeled, and genuinely unique to your business.

Applying the Framework

When evaluating your own technology investments, ask:

For each major initiative:

• Could a well-funded competitor replicate this in 3-6 months?

• Are we buying this capability or building it?

• Does this solve a problem unique to us, or a common problem in a novel way?

• Will this materially change our competitive position, or just create incremental improvement?

For your overall strategy:

• What capabilities do we have that competitors genuinely cannot match?

• How are we testing whether these advantages remain defensible?

• Are we investing in building new moats to replace ones competitors are eroding?

The answers should guide where you invest innovation resources. Build features where necessary, but invest in defensible advantages.

Why This Matters for Growing Companies

Early-stage companies can often win on execution speed and product quality alone. But as you scale, competitors notice. They copy what works. The advantages that got you to Series A won't get you to Series C.

This is where many scale-ups struggle. They've built good products with innovative features, but they haven't built defensible moats. When larger competitors notice them, or when well-funded startups enter their space, they discover their "competitive advantages" weren't defensible at all.

The companies that successfully navigate this transition are the ones that consciously invest in defensibility from the start, even when it's harder and more expensive than buying vendor solutions or copying competitor features.

The Radycle Perspective

At Radycle, we help companies navigate exactly this challenge. Whether you're a scale-up trying to build defensible advantages before competitors notice you, or an established company trying to transform without losing your moat, the question is the same: are you building features or building defences?

This requires understanding what's genuinely defensible in your specific market, how to structure teams to build proprietary capabilities rather than buying generic solutions, and when to invest in the harder, slower work of building moats versus the easier work of adding features.

If you're facing questions about where to invest innovation resources, how to evaluate whether your technology creates competitive advantage, or how to build capabilities competitors can't replicate - these are challenges we help leadership teams work through.

What's your experience? Have you seen companies confuse innovation with defensibility? Or found ways to build genuinely defensible advantages?

I'd be interested in hearing your stories - drop a comment or reach out at info@radycle.com.